Biomarker predicts long-term risk of breast cancer recurrence

A comparison of three methods of predicting the risk of recurrence in women treated for estrogen-receptor (ER)-positive breast cancer finds that only the breast cancer index (BCI) — a biomarker based on the expression levels of seven tumor-specific genes — accurately identifies patients who continue to be at risk after five years of treatment with either tamoxifen or the aromatase inhibitor anastrozole. The study comparing the BCI with two other prognostic tests has been published online in Lancet Oncology.

via Biomarker predicts long-term risk of breast cancer recurrence.

TLS Detox Kit

TLS Detox Kit What Makes the TLS® Detox Kit Unique?The TLS Detox Kit combines four of our most popular products to support your health, wellness and weight loss. Shed pounds and bodily waste with the TLS Detox kit and save over 28%!The NutriClean® System &md... See details

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: